Tag Archives: Anthony Durkacz

Podcasts, The Exchange for Entrepreneurs

Anthony Durkacz on Building a Turnaround at FSD Pharma | The CSE Podcast Ep6-S2

Audio

CSE’s Barrington Miller is joined by Anthony Durkacz, Interim CEO of FSD Pharma (CSE:HUGE) to discuss the company’s recent history and transition from the cannabis-era to new opportunities in the growing psychedelics space.

Here’s an overview of what Barrington and Anthony discuss in this edition of the “Exchange for Entrepreneurs” podcast:

0:00 – Introducing Anthony Durkacz, Interim CEO of FSD Pharma
5:45 – Working back towards a 1Bn market cap
8:10 – The latest investment in Lucid Psycheceuticals Inc. and treating MS
10:50 – The psychedelics movement
14:13 – Listing on NASDAQ

About FSD Pharma Inc.
FSD Pharma, Inc., is a publicly traded holding company since May 2018.

FSD BioSciences, Inc., a wholly-owned subsidiary, is a specialty biotech pharmaceutical R&D company focused on developing over time multiple applications of its lead compound, FSD201, ultra-micronized palmitoylethanolamide (PEA). Ultra-micro PEA is known to target the CB2 receptors of the endocannabinoid system of the human body and acts by down-regulating the pro-inflammatory cytokines to effectuate an anti-inflammatory response.

The company has successfully completed Phase 1 first-in-human safety and tolerability study for FSD201 and has found the compound to be safe with no serious adverse side effects. This study also validated considerable scientific literature already published in the European Union that claims safety and tolerability of micro-PEA. Ultra-micro PEA is currently beings dispensed in Italy and Spain as a prescription based medical food supplement since 2004.

The company received permission from the Food and Drug Administration (FDA) on June 1, 2020 to submit an Investigational New Drug Application (IND) for the use of FSD201 to treat COVID-19, the disease caused by the SARS-CoV-2 virus.

Severe COVID-19 is characterized by an over-exuberant inflammatory response that may lead to a cytokine storm and ultimately death. The Company is focused on developing FSD201 for its anti-inflammatory properties to avoid the cytokine storm associated with acute lung injury in hospitalized COVID-19 patients.

Learn more about FSD Pharma at FSD Pharma Inc. Subordinate Voting Shares | CSE – Canadian Securities Exchange (thecse.com)

Subscribe: Apple Podcasts / Spotify / Stitcher / Google Podcasts / iHeart / RSS
Market Open

FSD Pharma Inc. Opens the Market at the CSE Media Centre

Video

The CSE welcomed FSD Pharma Inc. (CSE:HUGE) to a Market Open at the CSE Media Centre on March 6th, 2020.

FSD Pharma Inc. is a specialty biotech pharmaceutical company that is targeting all legal aspects of the cannabis industry, including cultivation, processing, and manufacturing. As a science-driven company, FSD Pharma’s mission is to leverage their world-leading hydroponic indoor cannabis facility to develop life-saving medicines based on cannabinoid science. It is currently focusing its research and development efforts on novel cannabinoid-based treatments for various ailments, including certain central nervous system disorders, autoimmune skin diseases, and chronic pain. The company is also a licensed producer of medicinal grade cannabis under Canada’s Cannabis Act and Regulation.

“It was indeed a great milestone for FSD Pharma to come back and ring the bell at the CSE,” said CEO Dr. Raza Bokhair, MD. “We have, from what I understand, become your first company that is dual-listed.”

He added, “We have now become one of twelve Canadian domicile companies that are dual-listed in the United States – [the] first CSE company that is dual listed in the United States. And I hope that we will soon be recognized in a league of our own, as the thrust of our business is advancing clinical trials through FDA approved processes.”

Other key executive members of the FSD Pharma team were also in attendance at the Market Open, including Executive Co-Chairman and Founder Anthony Durkacz, and President and Founder Zeeshan Saeed.

View the podcast on this Market Open featuring Dr. Raza Bokhari here.

For more details about the CSE Media Centre, including information on upcoming Market Opens, please visit the CSE website, or follow us on social media.

#HashtagFinance, Podcasts

Anthony Durkacz on the Importance of Being Operationally Savvy

Audio

Anthony Durkacz, Chair of the Board of Directors at World Class Extractions (CSE:PUMP), joins Barrington Miller after opening the market to discuss how a cancer diagnosis helped inspire him to become an entrepreneur (1:24), why he believes the legalization of cannabis edibles in Canada could be a tailwind for the extraction industry (8:31), the operational benefits of the company’s recent merger with Quadron Cannatech (10:28), and what they’re focused on for the immediate future (15:23). Listen until the end to learn more about Anthony’s history with the CSE, the importance of scalable and efficient operations, and why he believes 2020 is “the year of the income statement.”

Subscribe:  Apple Podcasts / Spotify / Soundcloud / Stitcher / Google Play / RSS
Market Open

World Class Extractions Opens the Market at the CSE Media Centre

Video

The CSE is pleased to announce that World Class Extractions (CSE:PUMP) opened the market at the CSE Media Centre on September 17th, 2019. World Class Extractions is a Canadian publicly traded company which operates through two vertically integrated subsidiaries, Soma Labs Scientific and Greenmantle Products.

The company provides scalable extraction and processing solutions for the cannabis and hemp industries, including proprietary industrial-grade equipment, custom processing facilities, ancillary products, and scientific services. This Market Open followed the merger of World Class Extractions and Quadron Cannatech, and helped celebrate the beginning of the company’s journey as a merged entity.

“It’s really exciting for us to be here at the Media Centre, ringing the bell for the CSE,” said CEO Rosy Mondin. “We’ve been listed since 2017 through Quadron Cannatech, so for us to ring today, it’s fantastic, as it follows our merger with World Class Extractions.”

“It was a merger of strengths,” added Chairman Anthony Durkacz. “At the end of the day they had a great operational team and great technology. We had great technology and great capital markets access.”

It was a pleasure to welcome the team from World Class Extractions to celebrate both the Market Open and the recent merger. For more details about the CSE Media Centre, including information on upcoming Market Opens, please visit the CSE website, or follow us on social media.